Novozymes A/S
CSE:NSIS B
Decide at what price you'd be comfortable buying and we'll help you stay ready.
DCF Value
The DCF Value for 
Novozymes A/S (NSIS B) under the Base Case is 36.94 DKK.
Compared with the current market price of 458.9 DKK, the stock appears
Overvalued by 92% .
DCF Model
Alpha Spread
Preferences
Our valuation system just got a major upgrade
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
Welcome back
New to Alpha Spread? Create free account
Keep researching NSIS B for free
- 3 stocks a week, starting with NSIS B
- AAPL, MSFT and more always open
- 3 AI Assistant questions a week
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more